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Abstract
Background: SHANK3 is a protein in the core of the postsynaptic density (PSD) and has a critical role in recruiting
many key functional elements to the PSD and to the synapse, including components of a-amino-3-hydroxyl-5-
methyl-4-isoxazole-propionic acid (AMPA), metabotropic glutamate (mGlu) and N-methyl-D-aspartic acid (NMDA)
glutamate receptors, as well as cytoskeletal elements. Loss of a functional copy of the SHANK3 gene leads to the
neurobehavioral manifestations of 22q13 deletion syndrome and/or to autism spectrum disorders. The goal of this
study was to examine the effects of haploinsufficiency of full-length Shank3 in mice, focusing on synaptic
development, transmission and plasticity, as well as on social behaviors, as a model for understanding SHANK3
haploinsufficiency in humans.
Methods: We used mice with a targeted disruption of Shank3 in which exons coding for the ankyrin repeat
domain were deleted and expression of full-length Shank3 was disrupted. We studied synaptic transmission and
plasticity by multiple methods, including patch-clamp whole cell recording, two-photon time-lapse imaging and
extracellular recordings of field excitatory postsynaptic potentials. We also studied the density of GluR1-
immunoreactive puncta in the CA1 stratum radiatum and carried out assessments of social behaviors.
Results: In Shank3 heterozygous mice, there was reduced amplitude of miniature excitatory postsynaptic currents
from hippocampal CA1 pyramidal neurons and the input-output (I/O) relationship at Schaffer collateral-CA1
synapses in acute hippocampal slices was significantly depressed; both of these findings indicate a reduction in
basal neurotransmission. Studies with specific inhibitors demonstrated that the decrease in basal transmission
reflected reduced AMPA receptor-mediated transmission. This was further supported by the observation of reduced
numbers of GluR1-immunoreactive puncta in the stratum radiatum. Long-term potentiation (LTP), induced either
with θ-burst pairing (TBP) or high-frequency stimulation, was impaired in Shank3 heterozygous mice, with no
significant change in long-term depression (LTD). In concordance with the LTP results, persistent expansion of
spines was observed in control mice after TBP-induced LTP; however, only transient spine expansion was observed
in Shank3 heterozygous mice. Male Shank3 heterozygotes displayed less social sniffing and emitted fewer
ultrasonic vocalizations during interactions with estrus female mice, as compared to wild-type littermate controls.
Conclusions: We documented specific deficits in synaptic function and plasticity, along with reduced reciprocal
social interactions in Shank3 heterozygous mice. Our results are consistent with altered synaptic development and
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any medium, provided the original work is properly cited.function in Shank3 haploinsufficiency, highlighting the importance of Shank3 in synaptic function and supporting a
link between deficits in synapse function and neurodevelopmental disorders. The reduced glutamatergic
transmission that we observed in the Shank3 heterozygous mice represents an interesting therapeutic target in
Shank3-haploinsufficiency syndromes.
Background
The Shank protein family
Shank proteins, which include Shanks 1, 2 and 3, were
first identified in a yeast two-hybrid assay using the gua-
nylate kinase-associated protein (GKAP, also called
SAPAP1, DLGAP1 and DAP-1) as bait [1]. GKAP is a
PSD-95-binding protein that forms an important compo-
nent of the postsynaptic density (PSD), where protein-
protein interactions between scaffolding proteins and
receptors are a key mechanism in assembling a functional
synapse [2]. Shanks are highly enriched in the PSD and
contain five domains for protein-protein interactions,
including an ankyrin repeat domain, an Src homology 3
(SH3) domain, a PSD-95/discs large/zonula occludens-1
(PDZ) domain, several proline-rich regions and a
C-terminal sterile a-motif (SAM) domain [3] (Figure 1).
The PDZ domain mediates the interaction of Shanks
with the COOH terminus of several different proteins,
including GKAP [1,4], G protein-coupled receptors [5,6]
and the COOH terminus of group I metabotropic gluta-
mate receptors (mGluRs) [7]. GKAP mediates the bind-
ing of Shanks to N-methyl-D-aspartic acid (NMDA) and
a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic acid
(AMPA) receptors [8]. In addition, the SAM domain
interacts with GKAP [7], while proline-rich regions of
the Shank proteins bind the mGluR-binding protein
Homer [7], actin-binding protein Abp-1 [9,10] and cor-
tactin (cortical actin-binding protein) [11], which pro-
motes polymerization of the actin cytoskeleton, an
important modulator of long-term synaptic plasticity
[12]. Shanks interact directly with AMPA receptors
through the SH3 domain [13]. Interaction of the ankyrin
repeats of Shanks with a-fodrin may mediate calmodu-
lin-mediated processes after synaptic stimulation through
interactions with actin and calmodulin [14]. Sharpin can
also interact with the Shanks [15] and may be involved in
activity-dependent modification in dendritic spines.
Shank proteins in synaptic biology
There are ~300 individual Shank molecules in a single
postsynaptic site, representing ~5% of the total protein
molecules and total protein mass in the site [16]. It
would therefore not be surprising that alteration in
Shank expression could profoundly affect synaptic mor-
phology and function. Such a crucial role for Shank
levels in synaptic function is supported by the observa-
tion that overexpression of Shank1 led to increased
spine size in neurons in culture [17]. Additional studies
showed that knockout of Shank1 leads to a decrease in
spine number and spine and PSD size, decreased levels
of GKAP and Homer, and reduced basal synaptic trans-
mission [18]. Furthermore, inhibition of Shank3 expres-
sion has been shown to reduce numbers of spines in
hippocampal neurons in culture and, conversely, when
Shank3 was introduced into aspiny cerebellar neurons
in vitro, the neurons developed spines with functional
glutamatergic synapses expressing NMDA, AMPA and
mGlu receptors [19].
Haploinsufficiency of SHANK3 in neurodevelopmental
syndromes
Chromosome 22q13 deletion syndrome (22q13DS, also
called Phelan-McDermid syndrome) was first described
in the early 1990s (reviewed in [20]). Affected indivi-
duals show global developmental delays with absent or
severely delayed expressive speech, and they may have
autism spectrum disorders (ASDs). Careful analysis of
the extent of the deletion in dozens of independent
cases indicated the presence of a small “critical region”
encompassing SHANK3 [21,22], providing the first line
of evidence that a dysfunction in SHANK3 may be
responsible for the neurobehavioral aspects of 22q13DS.
The second line of evidence was the demonstration of a
recurrent breakpoint in SHANK3 in some cases with
22q13DS [23,24], which led these authors to conclude
that disruption of this single gene might be sufficient to
cause 22q13DS. Third, there are translocations in
SHANK3 that lead to 22q13DS [25]. Finally, several
recent studies demonstrated that even de novo point
mutations in SHANK3 can produce the entirety of neu-
rodevelopmental symptoms of 22q13DS, including glo-
bal developmental delay, absent or severely delayed
expressive speech, and ASDs [26-28]. Neurobehavioral
phenotypes associated with mutation or deletion of
SHANK3 are here referred to as SHANK3-haploinsuffi-
ciency syndromes and, as noted above, can be associated
with ASDs. Interestingly, overexpression of SHANK3
may also result in an ASD as evidenced by reports of
Asperger syndrome in an individual with three copies of
the SHANK3 locus [27]. Recently, de novo missense and
nonsense mutations in SHANK3 have been described in
atypical schizophrenia (with mild to moderate intellec-
tual disability, early onset and dysmorphic features [29]).
Mutations in the highly related gene SHANK2 have also
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disability [29-31].
In the current study, we characterized mice with a tar-
geted disruption of Shank3 as a model for SHANK3-
haploinsufficiency syndromes. We focused on synaptic
biology and synaptic function as the most proximal tar-
get for altered Shank3 expression. We also examined
social interaction and social communication in Shank3
heterozygotes and their wild-type littermates. The
results are consistent with an important role for
Figure 1 Reduced expression of Shank3 in Shank3-deficient mice. (A) Targeting strategy. Top: The genomic structure of Shank3 is shown.
The position of the 22t and 32t transcripts are also shown, as is the epitope for antibody N69/46. Bottom: The location of the loxP sites
introduced for targeting are shown before and after the activity of the recombinase. The green bar in the wild-type allele indicates the FRT site
remaining after deletion of the selection cassette. (B) Expression of Shank3 mRNA. Brain-derived mRNA from wild-type, heterozygous and
knockout mice were subjected to quantitative polymerase chain reaction (qPCR) assay for Shank3 mRNA using probes across exons 6 and 7 with
normalization against reference genes. (C) Expression of Shank3 in postsynaptic density (PSD) fractions. PSD fractions from wild-type,
heterozygous and knockout mice were subjected to immunoblotting with antibody N69/46 to Shank3. The migration of molecular weight
markers is shown on the left (in kilodaltons) and an immunoblot for bIII-tubulin as a loading control is shown below. WT, wild-type mice; Het,
Shank3 heterozygous mice; KO, homozygous knockout mice. *P < 0.0003.
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cate specific pathways as potential therapeutic targets
for SHANK3-haploinsufficiency syndromes.
Methods
Generation of mice with a disruption of the Shank3 gene
Animal procedures were approved by the Mount Sinai
School of Medicine and the National Institute of Mental
Health Animal Care and Use committees. We made use
of gene targeting in Bruce4 C57BL/6 embryonic stem
(ES) cells [32] to generate a mouse line that has loxP
sites inserted before exon 4 and after exon 9 (encoding
the ankyrin repeats), with the selection cassette (flanked
by FRT sites) excised by FLP recombinase. This floxed
strategy was chosen to allow us the option of doing con-
ditional (region-specific) knockouts if needed. C57BL/6
was used as the chosen embryonic stem cell line
because of the more robust social and cognitive abilities
in this line as compared to many of the 129-derived ES
lines. For all studies reported here, the floxed allele was
first excised by crossing with a CMV-Cre transgenic line
(again on a C57BL/6 background) that has ubiquitous
Cre expression and a line maintained with a deletion of
exons 4 through 9. This Shank3-deficient line was car-
ried forward by crossing heterozygotes with the C57BL/
6 strain to maintain a pure C57 background suitable for
electrophysiology and behavioral analyses.
Quantitative polymerase chain reaction
RNA was extracted from brain cortex using the RNeasy
Mini Kit (Qiagen, Valencia, CA, USA) according to the
manufacturer’s instructions. cDNA was synthesized with
the High Capacity cDNA Reverse Transcription Kit
(Applied Biosystems, Carlsbad, CA, USA). The universal
probe library (UPL) system (Roche, Indianapolis, IN,
USA) was used to perform quantitative polymerase chain
reaction (qPCR). Primers located in exons 6 and 7 of
Shank3 (NM_021423) were designed using ProbeFinder
Software (Roche). Three reference genes (Actb, Gapd and
Rpl13a) were used for normalization, and relative expres-
sion levels were calculated using qBase software [33],
now available from Biogazelle (Ghent, Belgium). Primer
sequences and UPL probe numbers were Shank3, for-
ward tggttggcaagagatccat, reverse ttggccccatagaacaaaag,
#1; Actb, forward ggatgcagaaggagattactgc, reverse ccacc-
gatccacacagagta, #63; Gapd, Fw gccaaaagggtcatcatctc,
reverse cacacccatcacaaacatgg, #29; Rpl 13a, forward
tccctgctgctctcaagg, reverse gccccaggtaagcaaactt, #41.
Unpaired t-tests were used for group comparisons.
Immunoblotting
PSD fractions were prepared as follows. Hemibrains of
wild-type, heterozygous and homozygous Shank3 mice
were homogenized in 2-[4-(2-hydroxyethyl)piperazin-1-
yl]ethanesulfonic acid (HEPES)-A containing 4 mM
HEPES, pH 7.4, 0.32 M sucrose, Protease Inhibitor
Cocktail and PhoSTOP Phosphatase Inhibitor Cocktail
(both from Roche). Nuclear fractions were precipitated
by centrifuging twice at 700 g for 15 min, and the
resulting supernatants were further centrifuged at
21,000 g for 15 min. The precipitates were resuspended
in HEPES-B containing 4 mM HEPES, pH 7.4, Protease
Inhibitor Cocktail and PhoSTOP Phosphatase Inhibitor
Cocktail, homogenized and rotated at 4°C for 1 hour.
The lysates were centrifuged at 32,000 g for 20 min and
washed twice with HEPES-C containing 50 mM HEPES,
pH 7.4, 0.5% Triton X-100, Protease Inhibitor Cocktail
and PhoSTOP Phosphatase Inhibitor Cocktail. Finally,
postsynaptic density fractions were resuspended in
HEPES-C containing 1.8% sodium dodecyl sulfate (SDS)
and 2.5 M urea. Fifty-two μg of each PSD fraction were
loaded to 4-12% SDS-polyacrylamide gel electrophoresis
(PAGE gel (Invitrogen, Carlsbad, CA, USA), transferred
to polyvinylidene fluoride membrane and immuno-
blotted with either the N69/46 anti-Shank3 antibody
directed against an epitope downstream of the PDZ
domain (UC Davis/NIH NeuroMab Facility, Davis, CA)
or the anti-ProSAP2 anti-Shank3 antibody directed
against the last 100 amino acids of Shank3 (Millipore,
Billerica, MA, USA). For bIII tubulin, the membrane
was stripped and immunoblotted with an anti-bIII tubu-
lin antibody (Abcam, Cambridge, MA, USA).
Hippocampal slice electrophysiology
Whole cell recording, two-photon time-lapse imaging
and analysis
Methods of recording, imaging and analysis were carried
out according to our previously published protocols
[34,35]. All experiments were conducted on CA1 pyrami-
dal cells at 32°C in acute slices taken from Shank3 hetero-
zygous mice and wild-type littermates. Spines were
visualized using calcein contained in the patch pipette,
making use of a two-photon laser scanning system modi-
fied from Olympus Fluoview FV 300 driven by a Chame-
leon two-photon laser (Coherent, Santa Clara, CA, USA).
Baseline synaptic responses were evoked using a glass pip-
ette positioned ~20 μm away from the imaged spines and
recorded at the soma. Long-term potentiation (LTP) was
induced with a θ-burst pairing (TBP) protocol in which
two trains of θ-burst stimuli (each train, separated by 20 s,
consisted of five bursts at 5 Hz, and each burst contained
five pulses at 100 Hz) were paired with brief, small postsy-
naptic depolarization. Volume analysis of individual spines
was performed as detailed previously [34]. Briefly, the inte-
grated fluorescence intensity inside a spine head was mea-
sured for individual spines at different time points and
normalized to the fluorescence intensity of the dendrites
from the same image stack to correct for potential changes
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(TBS) experiments was also calculated using the Rayburst
algorithm in NeuronStudio software (available from the
Computational Neurobiology and Imaging Center, Mount
Sinai School of Medicine, New York, NY, USA) following
deconvolution of the data [37-39], and we obtained similar
results using either approach.
Extracellular recordings
Hippocampal slices (350 μm thick) were prepared from
4- to 6-week-old heterozygous mice and their wild-type
littermate controls. Slices were perfused with Ringer’s
solution containing (in mM): NaCl, 125.0; KCl, 2.5;
MgSO4,1 . 3 ;N a H 2PO4,1 . 0 ;N a H C O 3, 26.2; CaCl2,2 . 5 ;a n d
glucose, 11.0. The Ringer’s solution was bubbled with 95%
O2 and 5% CO2 at 32°C during extracellular recordings
(electrode solution: 3 M NaCl). Slices were maintained for
1 hour prior to establishment of a baseline of field excita-
tory postsynaptic potentials (fEPSPs) recorded from stra-
tum radiatum in area CA1, evoked by stimulation of the
Schaffer collateral-commissural afferents (100-μsp u l s e s
every 30 s) with bipolar tungsten electrodes placed into
area CA3 [40]. Test stimulus intensity was adjusted to
obtain fEPSPs with amplitudes that were one-half of the
maximal response. The EPSP initial slope (mV/ms) was
determined from the average waveform of four consecu-
tive responses. Input-output (I/O) curves were generated
by plotting the fEPSP slope versus fiber volley amplitude
in low-Mg
2+ (0.1 mM) solution. AMPA receptor-mediated
and NMDA receptor-mediated I/O relationships were
measured in the presence of 2-amino-5-phosphonopenta-
noic acid (APV; 50 μM) and 6-cyano-7-nitroquinoxaline-
2,3-dione (CNQX; 100 μM), respectively (Sigma, St. Louis,
MO, USA).
Paired-pulse responses werem e a s u r e dw i t ha ni n t e r -
stimulus interval (ISI) of 50 ms and are expressed as the
ratio of the average responses to the second stimulation
pulse (FP2) to the first stimulation pulse (FP1). LTP was
induced by either a high-frequency stimulus (four trains
of 100-Hz, 1-s stimulations separated by 5 min) or TBS
(15 bursts of four pulses at 100 Hz separated by 200
ms). To induce long-term depression (LTD), Schaffer
collaterals were stimulated by low-frequency stimulation
(LFS; 900 pulses at 1 Hz, 15 min) or by a paired-pulse
low-frequency stimulation (PP-LFS; 1 Hz for 20 min,
50-ms interstimulus interval [41]) to induce mGlu
receptor-dependent LTD. Data were expressed as means
± SD, and statistical analyses were performed using ana-
lysis of variance (ANOVA) or Student’s t-test, with sig-
nificance set at an a level of 0.05.
Measurement of GluR1-immunoreactive puncta
Immunohistochemistry
Three-month-old animals were anesthetized with 250 μl
of 15% chloral hydrate and perfused transcardially with
1% paraformaldehyde for 1 min followed by 4% parafor-
m a l d e h y d ef o rat o t a lo f1 3m i n .T h eb r a i n sw e r et h e n
removed, hemisected, cut in 50-μm-thick sections using
a Leica VT1000S Vibratome (Vibratome, Bannockburn,
IL, USA) and subsequently stored in phosphate-buffered
saline (PBS) until use. Sections were incubated at 37°C
for 5 min, followed by incubation in acidified pepsin
(1 ml in a 0.2 N HCl solution) for 6.5 min. The tissue
was then washed at room temperature in PBS-B (3 × 20
min) and incubated in a 0.3% Triton X-100, 0.5% bovine
serum albumin (BSA), 5% normal goat serum for 1 h on
an orbital shaker. The blocking step was followed by
overnight incubation in the primary antibody (rabbit
polyclonal antiglutamate receptor 1 AB1504; Millipore,
Billerica, MA, USA), which was made in blocking solu-
tion at the appropriate dilution (1 μg/ml). The tissue
sections were then washed in PBS-B (5 × 5 min) and
incubated in secondary antibody (goat antirabbit Alexa
Fluor 488, Invitrogen) in a 2% BSA and 0.3% Triton
PBS-B solution at the appropriate dilution (1:400) for
1 h at room temperature on an orbital shaker. Finally,
the tissue was washed in PBS - B( 3×5m i n ) ,s t a i n e d
with 4”,6"-diamino-2-phenylindole-2HCl (DAPI) and
mounted on charged Aqua ColorFrost slides using Vec-
tashield mounting medium (Vector Laboratories, Burlin-
game, CA, USA).
Tissue sampling
To quantify puncta, we used a systematic random sam-
pling approach whereby a 1:6 series of sections were
stained, the stratum radiatum of the CA1 was contoured
using SteroInvestigator (MBF Bioscience, Williston, VT,
USA) and the sampling sites were determined using an
optical fractionator with the size of the grid set at 18 μm
2
(the dimension of the confocal image stacks to be later
sampled with a ×100 lens objective), at a digital zoom of
5 on a Zeiss LSM510 META confocal microscope (Zeiss,
Oberkochen, Germany). The trace of the contoured area
with an optical fractionator sampling grid placed on it
w a su s e da sag u i d et oo b t a i nc o n f o c a li m a g es t a c k so f
the above-mentioned dimensions that were 100 μm apart
from each other (i.e., the size of the probe).
Confocal imaging and puncta quantification
The fluorescent puncta were visualized under a ×100 oil
immersion objective (1.4 numerical aperture) in a series
of Z-stacks using an Argon/2 laser (488 nm wavelength)
at 50% output (tube current of 6.4 A and maximum
power of 30 mW), with a collection band pass spectrum
of 505-550 nm (with the following laser and microscope
settings: image frame size of 512 × 512, 1 Airy unit,
refractive index correction of 0.9144 and Z stack interval
of 0.1 μm( x,y pixel size = 0.05 μm)) and their intensity,
number and size quantified. These settings were opti-
mized during pilot studies and held constant throughout
the study.
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AutoDeblur 1.4.1 (Media Cybernetics, Bethesda, MD,
USA), using an adaptive point-spread function (PSF)
deconvolution method with a theoretical PSF, and then
analyzed with custom Vamp2D software [42] that reli-
ably calculates the size of individual puncta on the basis
of three-dimensional estimates and circumvents the
problem of object superimposition found with more
traditional methods that collapse the stacks into two-
dimensional projections. The relative density of puncta
was then calculated per cubic micrometer, and the dif-
ferences between groups were assessed using the non-
parametric Mann-Whitney U test.
Behavioral analyses
Shank3 wild-type and heterozygote breeding pairs were
imported from Mount Sinai School of Medicine to the
National Institute of Mental Health. Mice were main-
tained by breeding C57BL/6 wild-type mice with Shank3
heterozygotes and housed in a conventional tempera-
ture- and humidity-controlled vivarium. Littermates
were housed by sex in mixed genotype groups of two to
four per cage on a 12:12-h circadian cycle with lights on
at 0600. Behavioral experiments were conducted
between 1000 and 1600 in dedicated testing rooms.
Developmental milestones were tested across postnatal
days 2-14, including measures of body weight, body
length, tail length, pinnea detachment, eye opening, inci-
s o re r u p t i o n ,f u rd e v e l o p m e n t , righting reflex, negative
geotaxis, cliff avoidance, grasping reflex, auditory startle,
bar holding, level screen and vertical screen as pre-
viously described [43,44]. In addition, the mice were
evaluated in a standard, automated three-chambered
social approach task as previously described [44].
Male-female social interactions were evaluated in a
5-min test session as previously described [43,45], with
the exception that subject males were group-housed and
individually tested in clean cages with clean litter. Each
of the 12 wild-type and 14 heterozygous male subject
mice, ages 2.5-4 months, was paired with a different
unfamiliar estrus C57BL/6J female. A digital closed-
circuit television camera (Panasonic, Secaucus, NJ, USA)
was positioned horizontally 30 cm from the cage. An
ultrasonic microphone (Avisoft UltraSoundGate conden-
ser microphone capsule CM15; Avisoft Bioacoustics,
Berlin, Germany) was mounted 20 cm above the cage.
Sampling frequency for the microphone was 250 kHz,
and the resolution was 16 bits. The entire apparatus was
contained in a sound-attenuating environmental cham-
ber (ENV-018V; Med Associates, St. Albans, VT, USA)
illuminated by a single 25-Watt red light. Videos from
the male subjects were subsequently scored by an inves-
tigator uninformed of the subject’s genotype on mea-
sures of nose-to-nose sniffing, nose-to-anogenital
sniffing and sniffing of other body regions, using Noldus
Observer software (Noldus Information Technology,
Leesburg, VA, USA) as previously described. Ultrasonic
vocalizations were played back and spectrograms were
displayed using Avisoft software [43,45]. Ultrasonic
vocalizations were identified manually by two highly
trained investigators blinded to genotype information,
and summary statistics were calculated using the Avisoft
package. Interrater reliability was 95%. Data were ana-
lyzed using an unpaired Student’s t-test.
Olfactory habituation/dishabituation testing was con-
ducted in male and female Shank3 wild-type and hetero-
zygous mice ages 2.5-4 months using methods
previously described [44,46,47]. Nonsocial and social
odors were presented on a series of cotton swabs
inserted into the home cage sequentially, each for
2 min, in the following order: water, water, water (dis-
tilled water); almond, almond, almond (1:100 dilution
almond extract); banana, banana, banana (1:100 dilution
artificial banana flavoring); social 1, social 1, social
1 (swiped from the bottom of a cage housing unfamiliar
sex-matched B6 mice); and social 2, social 2, social
2 (swiped from the bottom of a second cage housing a
different group of unfamiliar sex-matched 129/SvImJ
mice). One-way repeated measures ANOVA was per-
formed within each genotype for each set of habituation
events and each dishabituation event, followed by a
Tukey post hoc test.
Results
Generation and characterization of a
Shank3-deficient mouse
We made use of gene targeting in Bruce4 C57BL/6
embryonic stem (ES) cells [32] to generate a mouse line
that has loxP sites inserted before exon 4 and after exon
9 (Figure 1A). For all studies reported here, the floxed
allele was excised and a line was maintained with a dele-
tion of exons 4 through 9. This line, which completely
deletes the ankyrin repeat domains of Shank3, produced
wild-type (+/+), heterozygous (+/-) and knockout (-/-)
animals with Mendelian frequencies from heterozygote-
heterozygote crosses.
qPCR showed 50% reduction of full-length Shank3
mRNA in the heterozygotes and complete loss in knock-
outs (Figure 1B). Moreover, there was no expression of
full-length Shank3 protein in PSD fractions from
Shank3-knockout mice and reduced expression in the
heterozygotes, using antibodies which cross-react either
with an epitope downstream of the PDZ domain (anti-
body N69/46; see Figure 1A) (Figure 1C) or with the
COOH terminal (data not shown), consistent with
haploinsufficiency.
Heterozygous and homozygous animals were viable
and showed no obvious alterations in gross brain
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there any obvious seizures. There was evidence for
subtle motor abnormalities in homozygotes, which is
being further characterized in ongoing studies. Both
genotypes were normal on measures of general health,
developmental milestones and exploratory activity, as
well as on social approach as measured in an automated
three-chambered social approach task.
Because SHANK3 haploinsufficiency is responsible for
the neurobehavioral phenotype in individuals with
22q13DS or SHANK3 mutations, we focused the studies
reported here on Shank3 heterozygous mice generated
by crossing wild-type mice with heterozygotes to be
most relevant to the clinical syndromes and to be most
useful in ultimately assessing potential therapeutic inter-
ventions in preclinical studies. A comprehensive investi-
gation of the knockout mice obtained through an
alternate breeding strategy (heterozygote-heterozygote
matings) is now in progress in independent experiments.
Basal glutamatergic synaptic transmission is reduced in
Shank3 heterozygous mice
To examine the role of Shank3 in regulating synaptic
glutamate receptor function, we studied glutamatergic
synaptic transmission in hippocampal slices. We exam-
ined the properties of basic transmission at Schaffer col-
lateral-CA1 synapses in hippocampal slices from 3- to
4-week-old Shank3 heterozygous mice and their litter-
mates using extracellular recordings. Plotting field exci-
tatory postsynaptic potential (fEPSP) slope versus
stimulus intensity demonstrated a reduction in the I/O
curves in the heterozygotes (data not shown), prompting
us to then further examine synaptic transmission in the
presence of inhibitors of specific subtypes of glutamate
receptors. In the presence of the NMDA receptor
antagonist APV, a decrease in AMPA receptor-mediated
field potentials in the heterozygous mice was seen,
reflected as a 50% decrease in the average slope of I/O
function compared with wild-type mice (n = 4 mice per
genotype, two to three slices per mouse; P = 0.001;
Figure 2A). In contrast, when the I/O relationship was
analyzed in the presence of the competitive AMPA/kai-
nate receptor antagonist CNQX to measure synaptic
NMDA receptor function, there was no difference
between genotypes (n = 4 mice per genotype, two to
three slices per mouse; P = 0.1; Figure 2B). These results
indicate that there is a specific reduction in AMPA
receptor-mediated basal transmission in the Shank3 het-
erozygous mice.
We asked whether the impairment of evoked synaptic
transmission in heterozygous mice is caused by altera-
tions in presynaptic and/or postsynaptic parameters. We
performed whole cell patch-clamp recordings in
3-month-old littermates and monitored spontaneous
miniature postsynaptic currents in the presence of tetro-
dotoxin (TTX). The amplitude of miniature excitatory
postsynaptic currents (mEPSCs) from hippocampal CA1
pyramidal neurons of heterozygous mice were signifi-
cantly smaller than those in control mice (n =7f o r
wild-type and n = 8 for heterozygous mice, P <0 . 0 1 ;
Figures 2C and 2D), which was evident by the signifi-
cant shift of the cumulative probability to the left
(Figure 2E), again indicating a reduction in basal trans-
mission. However, in heterozygous mice, the frequency
of miniature excitatory postsynaptic currents was signifi-
cantly higher (n = 7 for wild-type and n = 8 for hetero-
zygous mice, P < 0.03; Figures 2C and 2D) and paired-
pulse ratio was decreased (n = 6 for wild-type and n =7
for heterozygous mice, P < 0.05; Figure 2F), which
revealed an additional, presynaptic alteration in the het-
erozygotes as well.
Long-term potentiation is impaired in Shank3
heterozygous mice
We next examined long-term potentiation (LTP) with
extracellular fEPSP recordings at Schaffer collateral/CA1
synapses. In the first set of experiments, LTP was induced
by tetanic stimulation of the Schaffer collaterals (four
trains of 100 Hz separated by 5 min). While initial expres-
sion of LTP was identical across the two genotypes, the
maintenance of LTP was clearly impaired in the heterozy-
gous mice (average percentage of baseline 120 min after
tetanus: 165.1 ± 8.8% in wild-type and 117.1 ± 9.5% in het-
erozygous mice, P = 0.004; Figure 3A). In an additional set
of experiments, we further tested TBS LTP (10 bursts of
four pulses at 100 Hz separated by 200 ms), which also
showed a significant decrease in the potentiation at 60
min after TBS in heterozygous mice (156.3 ± 9.2% of base-
line in wild-type and 126.0 ± 8.9% in heterozygous mice,
measured 60 min after TBS, P = 0.007; Figure 3B).
In contrast to the altered synaptic plasticity observed
with LTP, long-term depression (LTD) induced by
either low-frequency stimulation (LFS) (82.6 ± 1.35% of
baseline in wild-type and 79.9 ± 2.5% in heterozygous
mice, measured 60 min after LFS, P > 0.1; Figure 3G) or
paired-pulse LFS (PP-LFS) stimulation (81.6 ± 6% of
baseline in wild-type and 82.7 ± 1.9% in heterozygous
mice, P > 0.1; Figure 3H) was not significantly changed
in heterozygotes.
Previous studies have shown that LTP is accompanied
by spine enlargement [35,48]. Therefore, it was of inter-
est to determine whether the deficits in LTP in the
Shank3 heterozygous mice were associated with altered
spine remodeling. We first established that spines from
wild-type mice were capable of structural modification
by simultaneously monitoring spine size and synaptic
responses in CA1 neurons before and after TBP [34,35].
We found that TBP produced a rapid and persistent
Bozdagi et al. Molecular Autism 2010, 1:15
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Page 7 of 15Figure 2 Altered basal synaptic properties in Shank3 heterozygous mice. (A) Reduced a-amino-3-hydroxyl-5-methyl-4-isoxazole-propionic
acid (AMPA) receptor responses in Shank3 heterozygous mice. Slices were incubated in the presence of 2-amino-5-phosphonopentanoic acid
(APV) and mean field excitatory postsynaptic potential (field EPSP) slope as a function of fiber volley is shown for slices derived from wild-type
and heterozygous mice. The inset shows representative traces for a given stimulus intensity (0.5 mA) in the input/output (I/O) graph (arrow
indicates the trace from wild-type; scale: 10 ms, 0.5 mV). (B) Normal N-methyl-D-aspartic acid (NMDA) receptor responses in Shank3
heterozygous mice. Slices were incubated in the presence of 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX), and mean field EPSP slope as a
function of fiber volley is shown. (C) Miniature excitatory postsynaptic currents (mEPSCs) from wild-type and Shank3 heterozygous mice. Left:
Amplitude of mEPSCs. *P < 0.01. Right: Frequency of mEPSCs. *P < 0.03. (D) Sample traces of mEPSCs. Scale: 1 s, 40 pA. (E) Cumulative
probability of mEPSC amplitude. (F) Paired-pulse ratio. Left: Representative EPSC traces from Shank3 heterozygous (red) and wild-type (black)
mice, with traces normalized to the first EPSC for comparison. *P < 0.05. WT, wild-type mice; Het, Shank3 heterozygous mice.
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Page 8 of 15Figure 3 Reduced long-term potentiation in Shank3 heterozygous mice. (A) Long-term potentiation (LTP) following high-frequency
stimulation. Field recordings of LTP induced with high-frequency stimulation (HFS; 4 times 100 Hz, separated by 5 min) as a function of time in
slices from wild-type and Shank3 heterozygous mice. (B) LTP following θ-burst stimulation (TBS). (C) Long-term depression (LTD) following low-
frequency stimulation (LFS), an NMDA receptor-dependent form of LTD. (D) LTD following paired-pulse low-frequency stimulation (PP-LFS), a
protein synthesis-dependent form of LTD. (E) LTP recorded with whole cell patch-clamp method. LTP was induced with θ-burst pairing (TBP). (E)
Normalized EPSP slope is shown as a function of time. (G) Representative EPSP traces before and after (arrow) LTP induction (scale bar: 5 mV, 10
ms). (F) Changes in normalized spine volume following LTP. (H) Representative images showing TBP-induced spine expansion in Shank3
heterozygotes. Images were acquired before and 5 min and 45 min after TBP. Transiently increased and stable spines are indicated by
arrowheads and arrow, respectively (scale bar: 1 μm). WT, wild-type mice; Het, Shank3 heterozygous mice.
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Page 9 of 15increase in spine volume concurrent with an immediate
increase in EPSP slope in whole cell recordings, which
gradually reached a plateau by ~30 min (Figures 3C-F).
However, in recordings from heterozygous mice, we
found that the stabilization in synaptic potentiation and
spine expansion were impaired in CA1 neurons (Figures
3C-F). In the heterozygous mice, both EPSP slope and
spine volume increased immediately to values compar-
able to those of control spines, but synaptic potentiation
and spine expansion failed to be sustained.
GluR1 immunoreactivity is decreased in Shank3
heterozygous mice
We then asked whether Shank3 haploinsufficiency can
lead to alterations in the numbers of AMPA receptor-
positive puncta, given the results from the electrophysio-
logical experiments and the relationship between synap-
tic strength and AMPA receptor subunit trafficking [49].
We carried out immunolabeling for GluR1 (an AMPA
receptor subunit) and quantified GluR1-immunoreactive
puncta (Figures 4A-G). Neurons from Shank3 heterozy-
gous mice showed significantly fewer GluR1-immunor-
eactive puncta (P < 0.005) consistent with the
electrophysiological data.
Behavioral analyses of Shank3 heterozygotes
To more extensively study social interactions in Shank3
heterozygous mice, we examined male-female social
interactions during a 5-min session of freely moving
reciprocal social interactions with an estrus B6 female
(Figure 5A). Cumulative duration of total social sniffing
by the male test subjects was lower in Shank3 heterozy-
gotes than in wild-type littermates (P = 0.02). In addi-
tion, fewer ultrasonic vocalizations were emitted by
heterozygotes than by wild-type littermates during the
male-female social interaction session (P = 0.003). Note
that while the equipment used could not distinguish
between calls emitted by the male subject and female
partner, the preponderance of calls during male-female
interactions in mice is usually emitted by the male [50].
As a control task to ensure that subject mice can
detect the social pheromones that elicit approach and
vocalizations, we measured olfactory abilities using the
olfactory habituation/dishabituation test. Habituation
and dishabituation were normal for social and nonsocial
odor cues in both wild-type and Shank3 heterozygous
mice (n = 8/genotype; Figure 5B). Both genotypes dis-
played the expected habituation, indicated by decreased
time spent in sniffing the sequence of three same odors,
and the expected dishabituation, indicated by increased
time sniffing the different odor (water habituation, wild-
type: P < 0.001; water habituation, heterozygotes: P <
0.001; almond habituation, wild-type: P = 0.015; almond
habituation, heterozygotes: P = 0.04; banana habituation,
wild-type: P < 0.001; banana habituation, heterozygotes:
P =0 . 0 3 3 ;s o c i a lo d o r1h a bituation, wild-type: P <
0.001; social odor 1 habituation, heterozygotes: P <
0.001; social odor 2 habituation, wild-type: P < 0.001;
social odor 2 habituation, heterozygotes: P < 0.001;
water to almond dishabituation, wild-type: P = 0.061;
water to almond dishabituation, heterozygotes: P =
0.118; almond to banana dishabituation, wild-type: P =
0.005; almond to banana dishabituation, heterozygotes:
P = 0.046; banana to social odor 1 dishabituation, wild-
type: P < 0.001; banana to social odor 1 dishabituation,
heterozygotes: P = 0.046; social odor 1 to social odor 2
dishabituation, wild-type: P < 0.001; social odor 1 to
social odor 2 dishabituation, heterozygotes: P < 0.001).
Discussion
In the present study, we summarize our results in mice
with a disruption of the full-length Shank3 protein. We
observed reductions in glutamatergic synaptic transmis-
sion and plasticity, including deficits in AMPA receptor-
mediated transmission and spine remodeling. We also
identified a reduced number of GluR1-immunoreactive
puncta in the striatum radiatum. Finally, we saw evi-
dence of social interaction and social communication
deficits in these mice. These results demonstrate the
importance of Shank3 in synaptic function, ultimately
leading to behavioral changes, which may be relevant to
the symptoms in individuals with SHANK3 mutations.
Development of the Shank3-deficient model
Our study targeted the full-length reference Shank3.
A recent report has indicated that there are additional
start sites in the human and mouse SHANK3 gene that
may lead to shorter products, truncated at the N termi-
nus (termed 22t and 32t in that report [51]). It is there-
fore possible that our Shank3-deficient mice are still
expressing shorter forms of Shank3 protein. We exam-
ined the possibility that there were high levels of such
shorter forms of Shank3 in mouse brain, making use of
an antibody with an epitope downstream of the PDZ
domain (antibody N69/46; see Figure 1A) that should
recognize both the longer form and the predicted
shorter (22t and 32t) forms (if expressed in the same
frame as the longer form) (see transcripts labeled 22t
and 32t in Figure 1A). In PSD fractions (see Figure 1)
and in mouse brain extracts [52], we saw strong expres-
s i o no fo n l yas i n g l ef o r ma n dl i t t l ee v i d e n c ef o rh i g h
expression of shorter forms. However, the caveat
remains that all deficits seen with deletion of the entire
SHANK3 gene (including 22t and 32t forms) may not be
fully recapitulated in the model presented here. We do
note that a de novo mutation in the ankyrin repeat
domain has been reported in a child with an ASD [27],
providing strong support for a role for loss of the longer
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Page 10 of 15Figure 4 Decreased density of GluR1-immunoreactive puncta in Shank3 heterozygous mice. (A and B) High-resolution confocal images of
puncta from wild-type and heterozygous mice. (C and D) The same images from Figures 4A and 4B are shown after deconvolution. (E and F)
The puncta were quantified after thresholding of fluorescence intensity. (G) Quantification of GluR1-immunoreactive puncta. *P < 0.005. WT,
wild-type mice; Het, Shank3 heterozygous mice.
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Page 11 of 15ankyrin repeat domain-containing form in neurodeve-
lopmental disabilities. Hence, disruption of this form, as
done in the current study, has direct construct validity
to ASD and to neurodevelopmental disabilities. It will
be of interest to determine where and to what levels the
22t and 32t forms are expressed and to assess whether
neuronal and/or other phenotypes are associated with
their disruption. Careful characterization of mice with a
disruption of Shank3 by targeting downstream exons
common to the full-length, 22t and 32t forms will be of
great interest, with the caveat that such targeting may
produce dominant-negative shorter products truncated
at the C-terminal that, depending on the exons targeted,
may or may not be relevant to known clinical mutations.
Synaptic development and function in Shank3
heterozygotes
Electrophysiological studies of the mice showed a
decrease in basal synaptic transmission in heterozygotes
when assessed by comparing either the I/O relationship
using field recordings or the amplitude of miniature
excitatory postsynaptic currents (mEPSCs) using patch
clamp recordings. This reduction in AMPA receptor-
dependent transmission is likely mediated by a decrease
in the number of synaptic AMPA receptors. Shank3
heterozygous mice also showed a decrease in the density
of GluR1-immunoreactive puncta, consistent with a
reduction in AMPA receptor levels. On the other hand,
both increase in mEPSC frequency and decrease in
paired pulse ratio in Shank3 heterozygous mice were
consistent with an increase in presynaptic release.
Transfection of Shank3 into aspiny cerebellar granule
cells has been shown to induce an increase in the
AMPA component of mEPSCs [19], and Shank3 is colo-
calized with GluR1-containing AMPA receptor in typical
spines [53]. In our studies, haploinsufficiency of Shank3
in vivo leads to reduced levels of AMPA receptors and
GluR1-positive puncta, results which are consistent with
such studies in vitro. However, while the postsynaptic
alterations in the Shank3-deficient mice are consistent
with studies carried out in vitro, understanding the
changes in presynaptic function observed in our analyses
will need further investigation. This presynaptic altera-
tion could be explained by compensatory mechanisms
in the Shank3 heterozygous mice to maintain constant
synaptic function. However, this compensatory effect
falls short as evidenced by the reduction in the I/O
relationship.
Selective acquisition of AMPA receptors is thought to
be a crucial mechanism for synapse maturation and
function, and our data confirm that Shank3 is an impor-
tant mediator of AMPA receptor recruitment and of
synaptic development.
Synaptic plasticity and spine remodelling in Shank3
heterozygotes
We examined LTP induced by either high frequency sti-
mulation or TBS. In Shank3 heterozygous mice, reduced
LTP was apparent at 30 min after induction in either
paradigm and no potentiation was observed at 120 min
after induction. However, the initial expression of LTP
was normal with either induction paradigm. We
observed similar deficits in the spine expansion that
normally accompanies LTP, such that the initial expan-
sion was normal in heterozygotes but quickly decayed to
baseline. The simplest explanation for these deficits is
an alteration in the trafficking of AMPA receptors to
synapses. AMPA receptor trafficking is involved in activ-
ity-induced changes in synaptic strength associated with
learning and memory [54], and synaptic insertion of
GluR1-containing AMPA receptors is required [55,56].
The quantity of surface receptors controls synaptic
strength [57-59]; therefore, reduction of both synaptic
transmission and plasticity in the Shank3 heterozygotes
would support a mechanism involving altered AMPA
receptor trafficking. Initial LTP is likely mediated by
phosphorylation of AMPA receptors, and the initial
spine expansion occurs in the absence of trafficking of
AMPA receptors [54]. However, AMPA receptor
Figure 5 Reduced social behaviors in Shank3 heterozygous and
wild-type littermate mice. (A) Adult male-female social
interactions. Left: Total duration of social interactions, scored as
cumulative seconds spent by the male subject in sniffing the nose,
anogenital and other body regions of an unfamiliar adult estrus B6
female mouse during a 5-min test session in a clean, empty mouse
cage. *P = 0.02. Right: Number of ultrasonic vocalizations emitted
during the social interaction test session (*P = 0.003) (n = 12 for
wild-type (WT) and n = 14 for heterozygous (Het) mice). (B)
Olfactory habitutation and dishabituation to nonsocial and social
odors, measured as cumulative time spent sniffing a sequence of
identical and novel odors delivered on cotton swabs inserted into a
clean cage (n = 8 mice/genotype).
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Page 12 of 15trafficking to the synapse is critical to sustain LTP and
spine expansion. The transient nature of synaptic poten-
tiation and spine enlargement in heterozygous mice is
consistent with normal phosphorylation of existing
synaptic AMPA receptors with a deficit in subsequent
consolidation, the process in which both structural and
functional forms of plasticity are progressively stabilized
over 30 min [34].
Social behavior in Shank3 heterozygotes
Male Shank3 heterozygous mice displayed reduced
responses to female social cues compared to their wild-
type littermates on parameters of social sniffing and
ultrasonic vocalizations in a male-female reciprocal
social interaction context. Given that Shank3 has a cen-
tral role in synaptic function, Shank3-related changes in
cellular and network components that underlie social
cognition could underlie the reduced social interactions
in Shank3 heterozygous mice. It was interesting that
social deficits were not observed in a three-chamber
social approach task, implying some specificity of the
social alterations. It will be of interest to better under-
stand the frequency of ASD and the characteristics of
social deficits in SHANK3-haploinsufficiency syndromes,
as it is already evident that this is not a universal finding
in these syndromes when considering 22q13DS or
schizophrenia.
The social deficits observed in the mice serve as
important reminders that systems outside the hippo-
campus that are involved in social behaviors will need
to be examined in these mice and that additional beha-
viors known to be mediated by the hippocampus will be
important for further investigations. Cellular and elec-
trophysiological analyses in additional brain regions and
large-scale behavioral studies are now underway for the
Shank3-deficient mice in the authors’ laboratories.
Conclusions
Haploinsufficiency of full-length Shank3 resulted in a
decrease in synaptic transmission, altered functional and
structural plasticity of synapses and reduced social beha-
viors. These findings are consistent with a model of
delayed synaptic development in Shank3 haploinsuffi-
ciency, together with a reduction in AMPA receptor
trafficking. The results highlight the importance of
Shank3 in synaptic development and function and sup-
port a link between deficits in synapse function and
neurodevelopmental disorders. To date, pharmacological
treatments for ASDs and other developmental disorders
(including SHANK3-haploinsufficiency syndromes) are
primarily ameliorative, focusing on managing associated
systems such as anxiety, aggression, repetitive behaviors,
attention deficits and epilepsy, among others (see, for
example, [60]). Pharmacological treatments addressing
core diagnostic symptoms, including, in ASDs, altera-
tions in reciprocal social interactions and communica-
tion, do not yet exist. Recently, the field has begun to
see the evaluation of therapies targeted to etiology (that
is, “personalized medicine”) using models of neurodeve-
lopmental disorders including fragile X, tuberous sclero-
sis, and Rett syndromes (see, for example, [61-64]). The
use of model systems such as the Shank3-deficient mice
reported here could lead to similar advances in the case
of SHANK3-haploinsufficiency syndromes. One interest-
ing outcome of the current study is that compounds
that enhance glutamatergic transmission, including
those that specifically enhance AMPA transmission
(AMPAkines) could possibly represent therapeutic
approaches in these conditions. Further analysis of this
and additional models may identify targets for novel
therapeutics for individuals with developmental delays
arising from 22q13 deletion syndrome or SHANK3
mutations.
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